Mucoadhesive Bioenhancer technology to improve bioavailability through the oral mucosa
The administration of active ingredients through the oral mucosa offers significant advantages over traditional delivery routes.
It bypasses first-pass hepatic metabolism, prevents gastric degradation, and enables faster and more efficient absorption, improving therapeutic efficacy and reducing systemic side effects.
The Mucoadhesive Bioenhancer technology leverages advanced mucoadhesive polymers and cyclodextrins to extend contact time with the oral mucosa, ensuring controlled release and enhanced bioavailability.
Benefits of Oral Mucosal Delivery
- Bypasses first-pass metabolism: ensures higher bioavailability.
- Prevents gastric degradation: protects sensitive actives from acid and enzymes.
- Food-independent absorption: consistent uptake regardless of meals.
- Faster onset of action: rapid systemic availability through mucosal absorption.
The Role of Mucoadhesion
Mucoadhesion is the ability of a material to adhere to the mucosal surface, prolonging the residence time of the formulation.
Mucoadhesive polymers enhance absorption and improve therapeutic efficacy by keeping the active in close contact with the mucosa for a longer period.
How Mucoadhesive Bioenhancer Works
The Mucoadhesive Bioenhancer combines bioadhesive gels and cyclodextrins to stabilize and transport active molecules across the mucosa.
This approach provides:
- Improved solubility and stability of actives.
- Enhanced epithelial permeability.
- Reduced pharmacokinetic variability.
- Sustained and controlled release for prolonged efficacy.
The formulation adheres efficiently to the sublingual epithelium, ensuring fast absorption and predictable results.
Examples of Suitable Actives
- Melatonin
- Vitamin D
- B-group vitamins
- Folic acid
- Coenzyme Q10
- Resveratrol
- Astaxanthin
These actives benefit from higher bioavailability, faster onset, and improved patient compliance.
Conclusion
Mucoadhesive Bioenhancer enables the enhancement of bioavailability and therapeutic efficacy for actives administered via the oral mucosa.
PJ Pharma, the ready-to-market line of Gruppo FarmaImpresa, offers Mucoadhesive Bioenhancer formulations available for private label and global distribution, supported by full regulatory and technical assistance.
